Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 15, 2023 07:00 ET | Source: EuMentis Therapeutics, Inc.

EuMentis Therapeutics Inc. Announces the First Closing of a Targeted $40M Series B Financing to Advance Novel Therapeutics to Treat Autism Spectrum Disorder, Tourette Syndrome and Traumatic Brain Injury

EuMentis is developing novel therapeutics with clinically validated mechanisms for the treatment of neurodevelopmental and neuropsychiatric conditionsEuMentis plans to initiate Phase 2 clinical trials...
February 08, 2023 07:00 ET | Source: EuMentis Therapeutics, Inc.

EuMentis Therapeutics Inc. Receives $3 Million Award from United States Department of Defense (DoD) to Advance its Novel NMDA Receptor Antagonist for Traumatic Brain Injury

Under the DoD award, EuMentis will conduct preclinical TBI studies in validated large animal model in collaboration with Dr. Todd Killbaugh at the Children’s Hospital of Philadelphia (CHOP) and plans...